HUMA - Humacyte, Inc.
IEX Last Trade
5.47
0.050 0.914%
Share volume: 163,226
Last Updated: Fri 27 Dec 2024 08:30:35 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$5.42
0.05
0.92%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2022-05-13 | 2022-08-12 | 2022-11-10 | 2023-03-24 | 2023-05-12 | 2023-08-14 | |
| Assets | |||||||
| Total Assets | 264.468 M | 246.365 M | 226.219 M | 204.302 M | 182.976 M | 168.106 M | |
| Current Assets | 209.295 M | 193.030 M | 174.612 M | 154.208 M | 133.855 M | 120.562 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 2.840 M | 2.694 M | 2.850 M | 2.298 M | 2.178 M | 5.958 M | |
| Short Term Investments | 2.840 M | 2.694 M | 2.850 M | 2.298 M | 2.178 M | 5.958 M | |
| Total Receivables | 233.000 K | 1.301 M | 31.000 K | 31.000 K | 0.000 | 0.000 | |
| Current Cash | 206.222 M | 189.035 M | 171.731 M | 151.879 M | 131.677 M | 114.604 M | |
| Total Non-current Assets | 55.173 M | 53.335 M | 51.607 M | 50.094 M | 49.121 M | 47.544 M | |
| Property Plant Equipment | 33.540 M | 32.227 M | 31.026 M | 30.039 M | 29.593 M | 28.543 M | |
| Other Assets | 21.633 M | 21.108 M | 20.581 M | 20.055 M | 19.528 M | 19.001 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 264.468 M | 246.365 M | 226.219 M | 204.302 M | 182.976 M | 168.106 M | |
| Total liabilities | 160.578 M | 104.105 M | 107.547 M | 87.374 M | 101.089 M | 106.989 M | |
| Total current liabilities | 10.763 M | 11.058 M | 17.906 M | 19.580 M | 23.601 M | 11.388 M | |
| Accounts Payable | 3.037 M | 2.537 M | 3.255 M | 1.595 M | 1.954 M | 2.362 M | |
| Other liabilities | 100.825 M | 44.239 M | 45.268 M | 27.973 M | 42.206 M | 77.987 M | |
| Current long term debt | 2.093 M | 2.162 M | 6.519 M | 10.877 M | 15.236 M | 2.455 M | |
| Long term debt | 48.990 M | 48.808 M | 44.373 M | 39.821 M | 35.282 M | 17.614 M | |
| Other liabilities | 100.825 M | 44.239 M | 45.268 M | 27.973 M | 42.206 M | 77.987 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 103.890 M | 142.260 M | 118.672 M | 116.928 M | 81.887 M | 61.117 M | |
| Common stock | 103.004 M | 103.006 M | 103.032 M | 103.164 M | 103.264 M | 103.362 M | |
| Retained earnings | -434.405 M | -397.537 M | -422.818 M | -426.538 M | -463.507 M | -486.213 M |